| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |